Ontology highlight
ABSTRACT: Background
Experimental treatments pass through various stages of development. If a treatment passes through early-phase experiments, the investigators may want to assess it in a late-phase randomised controlled trial. An efficient way to do this is adding it as a new research arm to an ongoing trial while the existing research arms continue, a so-called multi-arm platform trial. The familywise type I error rate is often a key quantity of interest in any multi-arm platform trial. We set out to clarify how it should be calculated when new arms are added to a trial some time after it has started.Methods
We show how the familywise type I error rate, any-pair and all-pairs powers can be calculated when a new arm is added to a platform trial. We extend the Dunnett probability an
SUBMITTER: Choodari-Oskooei B
PROVIDER: S-EPMC7263043 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature